Modalis Therapeutics Statistics
Total Valuation
TYO:4883 has a market cap or net worth of JPY 5.70 billion. The enterprise value is 2.14 billion.
Market Cap | 5.70B |
Enterprise Value | 2.14B |
Important Dates
The last earnings date was Wednesday, May 7, 2025.
Earnings Date | May 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TYO:4883 has 74.94 million shares outstanding. The number of shares has increased by 74.57% in one year.
Current Share Class | 74.94M |
Shares Outstanding | 74.94M |
Shares Change (YoY) | +74.57% |
Shares Change (QoQ) | +6.97% |
Owned by Insiders (%) | 7.95% |
Owned by Institutions (%) | 6.76% |
Float | 68.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | 1.72 |
P/TBV Ratio | 1.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -1.41 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.52
Current Ratio | 10.52 |
Quick Ratio | 10.38 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -629.24 |
Financial Efficiency
Return on equity (ROE) is -69.94% and return on invested capital (ROIC) is -61.09%.
Return on Equity (ROE) | -69.94% |
Return on Assets (ROA) | -54.68% |
Return on Invested Capital (ROIC) | -61.09% |
Return on Capital Employed (ROCE) | -68.70% |
Revenue Per Employee | n/a |
Profits Per Employee | -108.01M |
Employee Count | 14 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.77% in the last 52 weeks. The beta is 0.14, so TYO:4883's price volatility has been lower than the market average.
Beta (5Y) | 0.14 |
52-Week Price Change | +11.77% |
50-Day Moving Average | 79.14 |
200-Day Moving Average | 102.28 |
Relative Strength Index (RSI) | 47.71 |
Average Volume (20 Days) | 1,866,820 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -2.29B |
Pretax Income | -1.51B |
Net Income | -1.51B |
EBITDA | n/a |
EBIT | -2.29B |
Earnings Per Share (EPS) | -27.11 |
Balance Sheet
The company has 3.56 billion in cash and n/a in debt, giving a net cash position of 3.56 billion or 47.50 per share.
Cash & Cash Equivalents | 3.56B |
Total Debt | n/a |
Net Cash | 3.56B |
Net Cash Per Share | 47.50 |
Equity (Book Value) | 3.31B |
Book Value Per Share | 44.98 |
Working Capital | 3.26B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TYO:4883 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -74.57% |
Shareholder Yield | n/a |
Earnings Yield | -26.55% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |